Olatec Therapeutics

Olatec Therapeutics

Pharmaceuticals, 800 5th Ave Apt 25D, New York, 10065, United States, 1-10 Employees

olatec.com

  • facebook
  • twitter
  • LinkedIn

Who is OLATEC THERAPEUTICS

Olatec is a privately held biopharmaceutical company developing a platform of safe, oral NLRP3 antagonist therapeutics, to treat and prevent a broad spectrum of acute and chronic inflamma...

Read More

map

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from OLATEC THERAPEUTICS

Olatec Therapeutics Org Chart and Mapping

VP-Level
Employees

Sophia Skouras

Investor Relations, Admin. & Operations

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Olatec Therapeutics

Answer: Olatec Therapeutics's headquarters are located at 800 5th Ave Apt 25D, New York, 10065, United States

Answer: Olatec Therapeutics's official website is https://olatec.com

Answer: Olatec Therapeutics's revenue is $1 Million to $5 Million

Answer: Olatec Therapeutics's SIC: 2834

Answer: Olatec Therapeutics's NAICS: 325412

Answer: Olatec Therapeutics has 1-10 employees

Answer: Olatec Therapeutics is in Pharmaceuticals

Answer: Olatec Therapeutics contact info: Phone number: Website: https://olatec.com

Answer: Olatec is a privately held biopharmaceutical company developing a platform of safe, oral NLRP3 antagonist therapeutics, to treat and prevent a broad spectrum of acute and chronic inflammatory diseases that are known to be mediated by Interleukin-1 (IL-1), including: arthritis, heart failure, asthma, Alzheimers disease, multiple sclerosis, type-2 diabetes, melanoma and breast cancers, among others. By selectively targeting NLRP3, the bodys first line response in the innate immune system, Olatecs lead compound, dapansutrile (lab code: OLT1177) inhibits the production of pro-inflammatory cytokines IL 1B and IL 18. Olatecs drug development team, working together over 10 years, is comprised of experienced management and international thought leaders that have unparalleled expertise in inflammation and immunology and have been involved in the discovery and development of first-line inflammation treatments in the market today. The Company conducts operations in the United States and Europe and maintains offices in New York and the Netherlands.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access